The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis

Cell Research

Volumn 21, Issue 2, 2011, Pages 275-289

  Fu, Junjiang ^a   Qin, Li ^a   He, Tao ^a,b   Qin, Jun ^a   Hong, Jun ^a   Wong, Jiemin ^c   Liao, Lan ^a   Xu, Jianming ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

E cadherin; epithelial mesenchymal transition; gene repression; metastasis; NuRD complex; TWIST

Indexed keywords

AUTOANTIGEN; CADHERIN; CHD4 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; MTA2 PROTEIN, HUMAN; RBBP7 PROTEIN, HUMAN; REPRESSOR PROTEIN; RETINOBLASTOMA BINDING PROTEIN 7; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST;

ANIMAL; ARTICLE; CANCER INVASION; CELL LINE; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; PHYSIOLOGY; PROMOTER REGION; RNA INTERFERENCE;

ANIMALS; AUTOANTIGENS; CADHERINS; CELL LINE; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RETINOBLASTOMA-BINDING PROTEIN 7; RNA INTERFERENCE; RNA, SMALL INTERFERING; TWIST TRANSCRIPTION FACTOR;

MUS;

EID: 79651474948     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.118     Document Type: Article

References (51)

1. Weinberg RA. The Biology of Cancer. New York: Garland Science, 2007.
2. Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68:3645-3654.
3. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, (Pubitemid 38798858)
4. Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006; 66:4549-4552.
5. Castanon I, Baylies MK. A Twist in fate: evolutionary compa-rison of Twist structure and function. Gene 2002; 287:11-22. (Pubitemid 34460565)
6. O'Rourke MP, Tam PP. Twist functions in mouse develop-ment. Int J Dev Biol 2002; 46:401-413.
7. Mironchik Y, Winnard PT Jr, Vesuna F, et al. Twist overex-pression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005; 65:10801-10809. (Pubitemid 41715228)
8. Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005; 65:5153-5162. (Pubitemid 40827324)
9. Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 2008; 367:235-241.
10. Cheng GZ, Chan J, Wang Q, et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67:1979-1987. (Pubitemid 46424214)
11. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a po-tential oncogene that inhibits apoptosis. Genes Dev 1999; 13:2207-2217. (Pubitemid 29426726)
12. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 2004; 6:625-630. (Pubitemid 40017705)
13. Wang X, Ling MT, Guan XY, et al. Identifcation of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 2004; 23:474-482. (Pubitemid 38175002)
14. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10:295-305.
15. Watanabe O, Imamura H, Shimizu T, et al. Expression of twist and wnt in human breast cancer. Anticancer Res 2004; 24:3851-3856. (Pubitemid 40468675)
16. Yan-Qi Z, Xue-Yan G, Shuang H, et al. Expression and signi-fcance of TWIST basic helix-loop-helix protein over-expres-sion in gastric cancer. Pathology 2007; 39:470-475. (Pubitemid 47450590)
17. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12:5369-5376. (Pubitemid 44497250)
18. Zhang Z, Xie D, Li X, et al. Signifcance of TWIST expres-sion and its association with E-cadherin in bladder cancer. Hum Pathol 2007; 38:598-606. (Pubitemid 46399887)
19. Yuen HF, Chua CW, Chan YP, et al. Signifcance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 2007; 50:648-658.
20. Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007; 26:5433-5438. (Pubitemid 47255925)
21. Brehm A, Langst G, Kehle J, et al. dMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties. EMBO J 2000; 19:4332-4341. (Pubitemid 30623744)
22. Guschin D, Wade PA, Kikyo N, Wolffe AP. ATP-dependent histone octamer mobilization and histone deacetylation mediated by the Mi-2 chromatin remodeling complex. Biochemistry 2000; 39:5238-5245. (Pubitemid 30257061)
23. Qian YW, Wang YC, Hollingsworth RE Jr, et al. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 1993; 364:648-652. (Pubitemid 23274725)
24. Zhang Y, Ng HH, Erdjument-Bromage H, et al. Analysis of the NuRD subunits reveals a histone deacetylase core com-plex and a connection with DNA methylation. Genes Dev 1999; 13:1924-1935. (Pubitemid 29407360)
25. Marhold J, Brehm A, Kramer K. The Drosophila methyl-DNA binding protein MBD2/3 interacts with the NuRD complex via p55 and MI-2. BMC Mol Biol 2004; 5:20.
26. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 2004; 1677:52-57. (Pubitemid 38327088)
27. Manavathi B, Kumar R. Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 2007; 282:1529-1533. (Pubitemid 47076673)
28. Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278:42560-42568.
29. Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, Kumar R. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development 2004; 131:3469-3479. (Pubitemid 39139892)
30. Toh Y, Nicolson GL. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 2009; 26:215-227.
31. Mazumdar A, Wang RA, Mishra SK, et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 2001; 3:30-37. (Pubitemid 32114829)
32. Cui Y, Niu A, Pestell R, et al. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpres-sion leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 2006; 20:2020-2035. (Pubitemid 44286702)
33. Fujita N, Kajita M, Taysavang P, Wade PA. Hormonal regula-tion of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 2004; 18:2937-2949. (Pubitemid 39577917)
34. Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003; 113:207-219. (Pubitemid 36514972)
35. Zhang H, Singh RR, Talukder AH, Kumar R. Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev 2006; 20:2943-2948. (Pubitemid 44771728)
36. Connerney J, Andreeva V, Leshem Y, et al. Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 2006; 235:1345-1357. (Pubitemid 43843917)
37. Li L, Cserjesi P, Olson EN. Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol 1995; 172:280-292.
38. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50:717-721. (Pubitemid 20054204)
39. Price JE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 1996; 39:93-102. (Pubitemid 26136507)
40. Roche AE, Bassett BJ, Samant SA, et al. The zinc fnger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex. J Mol Cell Cardiol 2008; 44:352-360.
41. Feng Q, Zhang Y. The NuRD complex: linking histone mo-dification to nucleosome remodeling. Curr Top Microbiol Immunol 2003; 274:269-290. (Pubitemid 36118995)
42. Le Guezennec X, Vermeulen M, Brinkman AB, et al. MBD2/NuRD and MBD3/NuRD, two distinct complexes with dif-ferent biochemical and functional properties. Mol Cell Biol 2006; 26:843-851. (Pubitemid 43146480)
43. Hendrich B, Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 2003; 19:269-277. (Pubitemid 36507009)
44. Dexter DL, Kowalski HM, Blazar BA, et al. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978; 38:3174-3181. (Pubitemid 9031291)
45. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52:1399-1405.
46. Chambers AF. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 2009; 69:5292-5293.
47. Fu J, Yoon HG, Qin J, Wong J. Regulation of P-TEFb elongation complex activity by CDK9 acetylation Mol Cell Biol 2007; 27:4641-4651. (Pubitemid 47016119)
48. Lombaerts M, van Wezel T, Philippo K, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 2006; 94:661-671. (Pubitemid 43361897)
49. Fu J, Jiang J, Li J, et al. Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity. J Biol Chem 2009; 284:6832-6840.
50. Frangioni JV, Neel BG. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal Biochem 1993; 210:179-187. (Pubitemid 23147952)
51. Yuan Y, Qin L, Liu D, et al. Genetic screening reveals an es-sential role of p27kip1 in restriction of breast cancer progres-sion. Cancer Res 2007; 67:8032-8042. (Pubitemid 47395137)